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Abstract: The goal of the PHAR-QA (quality assurance in European pharmacy education 
and training) project is the production of a European framework for a quality assurance 
system based on competences for pharmacy practice. The PHAR-QA framework will be 
European, consultative and will encompass the various aspects of pharmacy practice.  
In this review, we describe the methodology to be used in the project and the first stage in 
the development of this framework. Using the proposals for competences produced by our 
previous PHARMINE (Pharmacy education in Europe) project, together with those of 
other sources, three university professors of pharmacy (Authors 2 through 4) produced a 
list of three major competency domains that reflect the activities of practitioners: Patient 
Care Competences, Personal Competences and Management and Organizational Structure 
Competences. Each domain was subdivided into nine, nine and eight competencies, 
respectively, for a total of 27 major competencies that were further subdivided into  
an average of five supporting competences per major competence, giving a total of  
140 proposals for competences for pharmacy practice. The 27 and 140 proposals were 
ranked by an expert panel of seven university professors of pharmacy (Authors 5 through 
11). The panel also commented on the proposed competences. On the basis of the ranks 
and comments, a list of 68 proposals for competences was produced. This list was then 
examined by the expert panel and a new version based on their comments produced.  
The latter process was repeated twice based on Delphi methodology. This review presents 
this process and the 68 proposals. We invite the pharmacy community to participate in the 
second stage of the elaboration of the PHAR-QA competence framework for pharmacy 
practice by ranking the proposals and adding comments. It is anticipated that this survey 
will stimulate a productive discussion on pharmacy education and practice by the various 
stakeholders (department staff and students, community, hospital and industrial 
pharmacists, as well as pharmacists working in clinical biology and other branches, 
together with representatives of chambers and associations). 
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1. Introduction 
The goal of the PHAR-QA (quality assurance in European pharmacy education and training) [1] 
project is the production of a European framework for a quality assurance system based on 
competences for pharmacy practice. 
The European Higher Education Area (EHEA) was launched in March, 2010. Similar to the 
Bologna Process (started in 1999), the EHEA is meant to ensure more comparable, compatible and 
coherent systems of higher education in Europe. The establishment of the European Higher Education 
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Area has led universities to harmonize their educational systems in order to amplify the mutual 
recognition of degree courses needed for student and professional mobility. This applies to all degree 
courses, not only pharmacy. Within the European Higher Education Area, the Bologna process 
developed university programs based on competences [2]. The use of competences eliminates 
ambiguity and clearly establishes what the student is able to do at the end of the program. 
The competence approach is also adopted in European directives. All EU pharmacy degree 
programs follow the European directive [3] for the recognition of qualifications for sectoral 
professions. In its latest 2013 version, programs are defined in terms of competences given the 
evolution in the role of pharmacists towards ensuring safety and efficacy in medicine use, reporting of 
adverse reactions to pharmaceutical products, personalized patient support and contribution to public 
health campaigns. Thus, the definition of programs in terms of competences is necessary, not only 
because of the changes brought about by the Bologna process, but also because of changes in the role 
of the pharmacist as defined in the EU directive. 
The elaboration of a list of competences that are harmonized across different countries, sectoral 
activities and education systems requires the use of an iterative process, such as the Delphi method [4]. 
The Delphi method is a process for structuring group communication, allowing a group of individuals, 
as a whole, to deal with a complex problem. This approach has been used for the elaboration of  
a framework of competences for medical doctors by the consortium “Medical Education in  
Europe” (MEDINE) [5]. This EU-funded thematic network used a modified Delphi iterative process to 
produce a series of outcomes for medical education. 
In this paper, we describe the results of the first stage in the production of an EU framework for 
competences for pharmacy practice using a modified Delphi process. We started with an expert panel 
consisting of university staff that elaborated through several Delphi rounds the framework to be used 
as a starting point in the second stage of this process. This second stage will consist in the evaluation 
of the framework by a much wider expert panel consisting of university staff, students, community 
pharmacists, hospital pharmacists, industrial pharmacists and others (laboratory medicine/clinical 
biology, wholesalers, pharmacists working in government and other agencies and representatives from 
pharmacy chambers and associations). 
2. Methods 
2.1. Elaboration of the List of Competences 
A questionnaire was produced by Authors 2 through 4 incorporating the principles outlined in the 
2013 EC directive on sectoral professions. The questionnaire was also based on the framework of 
competences for pharmacists produced by the PHARMINE (Pharmacy education in Europe) [6] work 
programme 3 [7] supplemented by frameworks developed for: 
 Medical doctors by MEDINE. 
 Dentists by ADEE [8]; the Association for Dental Education in Europe (ADEE) was founded in 
1975 as an independent European organisation representing academic dentistry and the 
community of dental educators (from their website). 
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 Community pharmacists in SW England [9]. The Competency Development and Evaluation 
Group (CoDEG) is a collaborative network of specialist and academic pharmacists, developers, 
researchers and practitioners. Its aim is to undertake research and evaluation in order to help 
develop and support pharmacy practitioners and ensure their fitness to practice at all levels. 
Among its key outputs are the General Level Framework and the Advanced Level Framework 
(from their website). 
In order to account for future developments in the role of pharmacists, trends in healthcare systems, 
especially those concerning pharmacy, were also taken into account. We used those outlined in the 
documents from the European Observatory on Health System and Policies [10]. 
A questionnaire with 27 major competences was developed as indicated below. The major 
competences were grouped into 3 major domains representing the main activities of the practitioner. 
(I) Domain “Patient Care Competences”, subdivided into 9 major competences: 
(1) Patient consultation 
(2) Need for the drug 
(3) Promote health, engage with the population on health issues and work effectively in a 
healthcare system 
(4) Selection of drug 
(5) Drug specific issues 
(6) Provision of drug product 
(7) Medicines information and patient education 
(8) Monitoring drug therapy 
(9) Evaluation of outcomes 
(II) Domain “Personal Competences” subdivided into 10 major competences: 
(10) Organisation 
(11) Effective communication skills both orally and in writing 
(12) Teamwork 
(13) Professionalism 
(14) Learning and knowledge 
(15) The global pharmacist 
(16) Problem-solving knowledge 
(17) Problem solving; effective use of information and information technology  
(18) Providing information 
(19) Follow-up 
(III) Domain “Management and Organization Competences” subdivided into 8 major competences: 
(20) Clinical governance 
(21) Service provision 
(22) Budget setting and reimbursement 
(23) Organisation 
(24) Training 
Pharmacy 2014, 2 165 
 
 
(25) Staff management 
(26) Procurement (medicines purchasing) 
(27) Drug product-process development and manufacture 
Each of the 27 major competences was further divided into an average of 5 supporting competences 
per major competence. Thus, for example, the major competence: “Personal Competences: learning 
and knowledge” was broken down into 7 proposals:  
(1) Capacity to learn, including continuous professional development; 
(2) Ability to teach others; 
(3) Analysis: ability to apply logic to problem solving, evaluating pros and cons and following up 
on the solution found; 
(4) Synthesis: capacity to gather relevant knowledge and summarise the key points; 
(5) Capacity to evaluate scientific data in line with current scientific and technological progress; 
(6) Ability to interpret pre-clinical and clinical evidence-based medical science and apply the 
knowledge to pharmaceutical practice; 
(7) Skills in scientific and biomedical research. 
This gave altogether a total of 140 proposals for competences that the panel had to rank.  
Complete details of the 140 proposals are available on the PHAR-QA website. 
The panel was asked to rank the 27 major competences and the 140 competences according to the 
following Likert [11] scheme: 
(1) Not important 
(2) Quite important 
(3) Very important 
(4) Essential 
2.2. Statistical Analysis 
Statistical analysis was performed using parametric and non-parametric methods with GraphPad

 
software [12]. We used the following methods: 
(1) Descriptive statistics 
i. Parametric: means and standard deviations 
ii. Non-parametric: medians with 25 and 75% percentiles 
(2) Tests of normality of distribution: 
i. Kolmogorov-Smirnov 
ii. Skewness 
iii. Kurtosis  
(3) Comparisons 
i. Non-parametric 
a. Kruskal–Wallis 
b. Wilcoxon signed rank test 
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3. Results 
3.1. Panel Members 
We analysed the differences amongst the rankings of panel members (Table 1). 
Minima (one) and maxima (four) were the same for all seven members. For 6/7, the median was 
three; means ranged from 3.0 to 3.6 (Table 1). The Kruskal–Wallis test revealed that the median 
ranking for expert panel Member 7 was different from the other six, but amongst the other six, there 
were no significant differences. There was a significant correlation between medians and means (test 
of slope significantly non-zero at p < 0.05). The Kolmogorov–Smirnov (K-S) test showed a significant 
deviation from the normality of distribution. All distributions showed significant critical values  
for skewness. 
Table 1. Statistical analysis of ranking data of the seven expert panel members. 
Panel member 1 2 3 4 5 6 7 
25% percentile 2.0 3.0 3.0 3.0 3.0 2.0 4.0 
Median 3.0 3.0 3.0 3.0 3.0 3.0 4.0 
75% percentile 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
Mean 3.0 3.2 3.2 3.1 3.2 3.1 3.6 
Standard deviation 0.89 0.77 0.72 0.90 0.72 0.96 0.75 
Kolmogorov-Smirnov 
(K-S) distance 
0.21 0.26 0.24 0.26 0.25 0.27 0.45 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Passed K-S  
normality test 
No No No No No No No 
Skewness −0.31 −0.62 −0.46 −0.69 −0.71 −0.70 −1.8 
Kurtosis −0.91 −0.47 −0.52 −0.51 0.44 −0.63 2.0 
3.2. Major Competences 
The rankings of the major competences were analysed (Table 2). 
Table 2. Statistical analysis of ranking data of the 27 major competences (ranked by 
mean). Med, median; SD, standard deviation; CV, coefficient of variation. 
Rank Major competence 
Domain-
number 
Med Mean SD CV% 
1 Selection of drug PCC-1.4 4 3.9 0.095 2 
2 Providing information PC-2.18 4 3.8 0.38 10 
4 
Problem solving: effective use of information and 
information technology 
PC-2.17 3.4 3.6 0.31 9 
5 Need for the drug PCC-1.2 3.3 3.6 0.43 12 
8 Provision of drug product PCC-1.6 3.5 3.5 0.53 15 
3 Drug specific issues PCC-1.5 3.4 3.5 0.23 6 
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Table 2. Cont. 
Rank Major competence 
Domain-
number 
Med Mean 
Std. 
dev. 
CV% 
9 
Effective communication skills both orally and  
in writing 
PC-2.11 3.6 3.4 0.67 20 
7 Procurement (medicines purchasing) MOC-3.26 3.3 3.4 0.53 16 
6 Medicines information and patient education PCC-1.7 3.3 3.3 0.37 16 
12 Problem-solving knowledge PC-2.16 3.3 3.3 0.2 6 
14 Professionalism PC-2.13 3.3 3.3 0.13 4 
10 Monitoring drug therapy PCC-1.8 3.1 3.3 0.38 12 
11 Follow-up PC-2.19 3 3.3 0.52 15 
13 Training MOC-3.24 3 3.3 0.57 17 
15 Learning and knowledge PC-3.24 3 3.2 0.39 12 
16 Patient consultation PCC-1.1 3.4 3.1 0.57 18 
17 
Promote health, engage with population on health 
issues and work effectively in a health care system 
PCC-1.3 3.1 3.1 0.43 14 
18 
Drug product-process development  
and manufacture 
MOC-3.27 2.9 2.9 0 0 
20 Clinical governance MOC-3.21 3 2.9 0.41 14 
19 Organisation MOC-3.23 2.8 2.8 0.55 19 
21 Teamwork PC-2.12 2.8 2.8 0.46 16 
23 The global pharmacist PC-2.15 2.8 2.7 0.54 20 
24 Staff management MOC-3.25 2.7 2.7 0.39 15 
22 Evaluation of outcomes PCC-1.9 2.5 2.6 0.38 14 
25 Organisation PC-2.10 2.3 2.3 0.9 13 
26 Service provision MOC-3.21 2.2 2.1 0.72 34 
27 Budget setting and reimbursement MOC-3.22 1.3 1.5 0.51 35 
PCC, Patient Care Competences; PC, Personal Competences; MOC, Management and Organization Competences. 
There was a significant correlation between medians and means (test of slope significantly  
non-zero at p < 0.05). Coefficients of variation ranged from 0–30%. The K-S test showed that for 5/27 
major competences (“selection of drug”, “providing information”, “drug specific issues”, “follow-up”, 
“learning and knowledge”), there were significant deviations from normality; in 5/27 (“providing 
information”, “drug specific issues”, “effective communication skills both orally and in writing”, 
“learning and knowledge”, “the global pharmacist”), there were significant degrees of skewness. 
The Wilcoxon signed rank test showed that all the medians for the major competences (except that 
for the 27th) were significantly different from a theoretical median ranking of one (= not important). 
Of the six high ranking major competences (rank: 1–4, 8 and 9; median > 3.4), three were Patient 
Care Competences and three Personal Competences. Of the eight lowest ranking major competences 
(rank: 19, 21–27; median < 2.8), four were Management and Organization Competences, one a Patient 
Care Competence and one a Personal Competence.  
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3.3. Ranking Data for All Competences 
Table 3 shows part of the statistical analysis of the ranking of the data of the 140 competences: the 
median rank for the three lowest ranked competences (left) was not different from a theoretical rank of 
one (= not important); the medians for the 6 highest ranked competences (right) were significantly 
different from 1. The 3 lowest ranked competences showed a wide range of scores from 1 through 4 
and very high coefficients of variability compared to the 6 competences that had the highest ranks. 
Although the Wilcoxon signed rank test comparison to a theoretical value of one (= not important)  
(W value) showed that the three lowest ranks had scores that were not significantly different from one, it 
should be noted that this is primarily due to the discrepancies of the positive ranks as negative ranks 
(i.e., ranks < 1) were all zero. 
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Table 3. Part of the statistical analysis of the ranking of the data of the 140 competences: data (left) for three lower ranked competences not 
different from a theoretical rank of one (= not important) and data (right) for six highest ranked competences (mean rank = 3.9) (for complete 
results for the 140 competences). K-S, Kolmogorov-Smirnov; W value, Wilcoxon signed rank test value. 
Rank Lowest Lowest Lowest Highest Highest Highest Highest Highest Highest 
Competence 
Describes the 
key drivers for 
national and 
local service 
development 
Claims 
reimbursement 
appropriately 
for services 
provided 
Ensures the 
prescriber’s 
intentions 
are clear 
Ensures 
appropriate 
timing of 
dose 
Supplies 
information 
on 
documents 
Accesses 
information 
from 
appropriate 
sources 
Demonstrates 
ability to 
describe the 
mechanisms of 
interactions 
Provides 
information that is 
appropriate to the 
recipient’s needs 
Establishes the 
priority of 
information 
provision when 
it is needed 
Median 2 2 4 4 4 4 4 4 4 
Minimum 1 1 1 3 3 3 3 3 3 
Maximum 3 4 4 4 4 4 4 4 4 
25% percentile 1 1 1 4 4 4 4 4 4 
75% percentile 3 2.5 4 4 4 4 4 4 4 
Mean 2 2 3 3.9 3.9 3.9 3.9 3.9 3.9 
Standard 
deviation 
0.82 1.1 1.4 0.38 0.38 0.38 0.38 0.38 0.38 
Coefficient of 
variation 
40.82% 54.77% 47.14% 9.80% 9.80% 9.80% 9.80% 9.80% 9.80% 
K-S distance 0.21 0.33 0.33 0.5 0.5 0.5 0.5 0.5 0.5 
p value 0.2 0.0359 0.0192 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Deviation from 
normality 
Yes No No No No No No No No 
W value 15 10 15 28 28 28 28 28 28 
Sum of + ranks 15 10 15 28 28 28 28 28 28 
Sum of − ranks 0 0 0 0 0 0 0 0 0 
p value 0.0625 0.125 0.0625 0.0156 0.0156 0.0156 0.0156 0.0156 0.0156 
Skewness 0 1.4 −0.99 −2.6 −2.6 −2.6 −2.6 −2.6 −2.6 
Kurtosis −1.2 2.5 −1.2 7 7 7 7 7 7 
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4. Discussion 
In this paper, we have presented the PHAR-QA survey modus operandi and the use of a Delphi 
method with a small-sized expert panel. Thus, this article is about how to determine competences; 
further articles will deal with the definitive competence framework. 
4.1. Likert Scales 
As the PHARMINE and PHAR-QA consortia work in close association with MEDINE, we used the 
four-point Likert scale used by the MEDINE consortium. During discussion with the MEDINE 
statisticians, they explained that their reasoning behind the use of a four-point, rather than a five-point 
scale, was that with a five-point scale, the middle ranking point, three (“moderately important”), can be 
taken as an “easy, no-choice option” and, so, bias the data in the case of long questionnaires. With the 
latter, the fatigue of filling in the questionnaire may lead panel members to consistently choose Rank 3 
for the sake of facility. The four-point scale makes answers requisite in that the responder is obliged to 
make a value judgement. 
However, during our development of the PHAR-QA questionnaire, the following question was 
raised several times: how does one accommodate for the fact that an expert panel member may simply 
not know and/or have no opinion on the ranking. This begs the question as to whether the possibility to 
express the absence of reply should be incorporated into the ranking scale and how. This could be done 
with a two-stage post-hoc analysis: (1) binary for “reply/no reply”; then (2) parametric/non-parametric 
for “analysis of ranking”. The solution chosen for the Delphi rounds with the European pharmacy 
community as the expert panel is the use of a four-point Likert scale plus an additional fifth option  
“I cannot rank this competence”. In future papers, the question of how this response can be analysed 
will be detailed. 
4.2. Statistical Analysis of the Rankings 
Examination of the data showed that: 
(1) There is a lack of sphericity: the variances of the differences between all possible pairs of 
rankings are not equal. The difference between Rank 1 (not important) and 2 (quite important) 
is not the same as between 3 (very important) and 4 (essential). 
(2) Data are discrete rather than continuous variables: rankings cannot take on any value between 
two specified values. 
(3) Data are skewed to higher ranking values. They do not follow any pre-specified distribution; 
some data even show an inverse bell-shaped form. In spite of this, there is a significant 
correlation between median and mean in several cases. This generally implies the normality of 
data, but in this case is probably affected by the small number of observations. Finally, it 
should be noted that there is a wide spread in values for the coefficient of variation. 
Although the characteristics above would argue in favour of the use of non-parametric methods, 
both parametric and non-parametric statistics have been used as follows: 
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(1) Descriptive statistics: reduce and summarize complex data to a few comprehensible variables 
without losing any of the original information. In this case, parametric statistics (means and 
standard deviations, coefficient of variation, etc.) are more useful, as they are more precise. 
(2) Decisional statistics: reveal the statistical importance of such variables while taking into 
account errors from known or unknown disturbing influences. In this case, non-parametric tests 
(Wilcoxon signed rank, Kruskal-Wallis, etc.) are more appropriate in the case of  
non-continuous variables, such as ranks, although parametric tests (analysis of variance, etc.) 
do show a certain robustness [13]. It should be noted that in the Wilcoxon comparison of the 
ranks observed with a theoretical rank of “1” (= not important), the test is affected by the fact 
that the sum of negative ranks = 0. This arises because there are no observed ranks <1.  
As Likert ranks are integral, a rank <1 would be equal to “0”, and this would bring in a binary 
scale of an “important/not important” nature. This is against the philosophy behind the Likert 
scale, which is used to create nuance in a questionnaire (not important, quite important, very 
important, essential) and so goes beyond a binary scale. 
Albeit, it should be remembered that no statistical analysis can give a correct answer to a wrong 
question or if used in unfavourable conditions. In order to be valid, the K-S, skewness and kurtosis 
tests of normality of distribution require a theoretical number of observations >25–30. With seven 
panel members, this condition is not met, so the results from the tests applied in such circumstances 
should be treated with caution. This is shown by the fact that in the analysis of the 27 major 
competences, in some cases (e.g., for “selection of drug”) the data did not pass the  
Kolmogorov-Smirnov test for normality and, yet, did not show statistical significance in the skewness 
and kurtosis tests. The opposite was also seen: for example, for “effective communication skills both 
orally and in writing”, the data showed significant skewness and, yet, passed the normality test.  
The design will be more balanced in the future when the expert panel will consist of several hundred 
persons. This will allow for a more accurate description of distributions and their deviation (or not) 
from normality. It will also allow cluster analysis of specific groups. 
4.3. The Modified Delphi Process and the Rankings of the Proposals (Figure 1) 
Figure 1. The modified Delphi process.  
 
• production by 3 university (pharmacy) staff members
• a starting point with 27 major competences and 
140 proposals for competences; to be modified in 
future rounds
1. INITIAL 
QUESTIONNAIRE
• expert panel of 7 university (pharmacy) staff members
• panel provide (1) ranking data, (2) comments (what is 
unclear, missing, in duplicate, etc.)
2. PANEL 
EVALUATION
• modified questionnaire produced using combination of 
statistics and comments
• questionnaire will be shorter (not to exceed 30 min 
filling in time) and user-friendly software will be applied 
with distribution by internet
3. MODIFIED 
QUESTIONNAIRE
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Figure 1. Cont.  
 
The above process has several characteristics: 
(1) It is a two-stage process with the first university staff panel producing a questionnaire that is 
run through a wider pharmacy community panel at a second stage. This will “even out” 
discrepancies between the different actors. Thus, for instance, several university staff members 
gave a low rank to management and organization competences (although there was wide 
variability on some of these points). It may be that active pharmacists will give such competences a 
higher rank. The process will ensure that the final framework is universally accepted. 
(2) The initial suggested framework is only a starting point: it may be modified by suggestions to 
remove or add competences as the process evolves. In the initial stages, it was realised that 
some competences were duplicates (e.g., major Competences 16 and 17); other competences 
were not described with sufficient clarity. There have also been changes in the organisation of 
the questionnaire. At the end of Stage 3 in Figure 1, PHAR-QA will put forward a proposal that 
represents a consensus (not unanimity) of the opinions of the expert panel members.  
This constitutes a starting point, and pharmacists around Europe will participate in order to 
ensure that the final proposed competences will have the widest possible acceptance. 
(3) The final framework will be validated by the large number of responses from pharmacists with 
widely varying occupations throughout Europe. Thus, the framework will be European, 
consultative and will encompass pharmacy practice in a wide sense. 
(4) In order to stimulate participation, the time needed to fill in the questionnaire is set at  
30 min; thus, the number of questions is limited to 60–70. 
4.4. Limitations 
The experience of the university staff expert panel outside of academia is unknown. Albeit, in the 
two-stage process we use, the questionnaire produced by the university staff expert panel is but a 
consensus starting point for the second stage. It is unknown how far an academically produced starting 
point questionnaire will influence the final result, i.e., the competence framework produced by the 
Delphi rounds in the wider EU pharmacy community. 
• expert panel from the pharmacy community (university 
staff, students, community pharmacists, hospital 
pharmacists, industrial pharmacists, and others 
(clinical biologists, etc.)
• panel provide ranking data and comments
4. PANEL 
EVALUATION
• modified questionnaire produced using combination 
of statistics and comments
• questionnaire may become shorter or longer
5. MODIFIED 
QUESTIONNAIRE
• repeat of stages 4 and 5 as required
• questionnaire may become shorter or longer
• final version will become the PHAR-QA framework
of competences
6. FINAL VERSION
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The second stage Delphi rounds will include staff, students, community pharmacists, etc., reflecting 
the heterogeneity of the EU pharmacy community. The sample of stakeholders should be reflective of 
the target population. Attention will be paid to collecting a sufficient number of replies from the 
different stakeholders in different countries in order to allow cluster analysis of possible trends in 
replies. There is a certain contradiction here with the need to fix numbers in stakeholder categories in 
terms of factors, such as the population of the country concerned, the relative numbers of staff and 
students in academia and other factors. 
5. Conclusions 
PHAR-QA has developed a proposal for a competence framework for pharmacy practice. This 
represents a consensus (not unanimity) of the opinions of the expert panel members. It constitutes a 
starting point upon which pharmacists around Europe are invited to comment and validate, giving a 
final competence framework with the widest possible acceptance. 
The questionnaire “The European network evaluation of the PHAR-QA framework of competences 
for pharmacists” can be found at the website given in [14]. 
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